Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Brenner

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Epidemiology and Infection|May 6, 2026
Global Distribution and Evolution of Human Metapneumovirus A2b2 Clade: Insights from Genomic SurveillanceMatthew David Bucala, Michael Brenner
Pharmacotherapy|September 26, 2015
Atomoxetine for Orthostatic Hypotension in an Elderly Patient Over 10 Weeks: A Case ReportGenevieve M Hale, Michael Brenner
Journal of Child Neurology|October 24, 2003
Alexander's disease: clinical, pathologic, and genetic featuresAnne B Johnson, Michael Brenner
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
The Effects of Ranolazine on Hemoglobin A1c in a Veteran PopulationLindsey Greiner, Kathryn Hurren, Michael Brenner
The Annals of Pharmacotherapy|February 27, 2016
Ranolazine and Its Effects on Hemoglobin A1CLindsey Greiner, Kathryn Hurren, Michael Brenner
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 4, 2015
Managing comorbidities in patients with chronic heart failure: first, do no harmBeth DeJongh, Kade Birkeland, Michael Brenner
Journal of Neuroscience Research|October 23, 2018
AP-1 and the injury response of the GFAP geneMichael Brenner, Albee Messing, Michelle L Olsen
The Annals of Pharmacotherapy|January 18, 2017
The Treatment of Primary Orthostatic HypotensionGenevieve M Hale, Jose Valdes, Michael Brenner
Human Molecular Genetics|June 12, 2010
Drug screening to identify suppressors of GFAP expressionWoosung Cho, Michael Brenner, Noel Peters, et al.
Glia|February 2, 2008
GFAP promoter elements required for region-specific and astrocyte-specific expressionYoungjin Lee, Albee Messing, Mu Su, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Epidemiology and Infection|May 6, 2026
Global Distribution and Evolution of Human Metapneumovirus A2b2 Clade: Insights from Genomic SurveillanceMatthew David Bucala, Michael Brenner
Pharmacotherapy|September 26, 2015
Atomoxetine for Orthostatic Hypotension in an Elderly Patient Over 10 Weeks: A Case ReportGenevieve M Hale, Michael Brenner
Journal of Child Neurology|October 24, 2003
Alexander's disease: clinical, pathologic, and genetic featuresAnne B Johnson, Michael Brenner
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
The Effects of Ranolazine on Hemoglobin A1c in a Veteran PopulationLindsey Greiner, Kathryn Hurren, Michael Brenner
The Annals of Pharmacotherapy|February 27, 2016
Ranolazine and Its Effects on Hemoglobin A1CLindsey Greiner, Kathryn Hurren, Michael Brenner
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 4, 2015
Managing comorbidities in patients with chronic heart failure: first, do no harmBeth DeJongh, Kade Birkeland, Michael Brenner
Journal of Neuroscience Research|October 23, 2018
AP-1 and the injury response of the GFAP geneMichael Brenner, Albee Messing, Michelle L Olsen
The Annals of Pharmacotherapy|January 18, 2017
The Treatment of Primary Orthostatic HypotensionGenevieve M Hale, Jose Valdes, Michael Brenner
Human Molecular Genetics|June 12, 2010
Drug screening to identify suppressors of GFAP expressionWoosung Cho, Michael Brenner, Noel Peters, et al.
Glia|February 2, 2008
GFAP promoter elements required for region-specific and astrocyte-specific expressionYoungjin Lee, Albee Messing, Mu Su, et al.
Pageof 10